NCT03400423View on ClinicalTrials.gov

The Acute Effects of Caffeine on Exercise and Cognition

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

August 1, 2019

Conditions
Adult Population
Interventions
DRUG

Caffeine

Oral administration of 1.2mg/kg of powdered caffeine with water.

BEHAVIORAL

Moderate Intensity Exercise

Moderate intensity exercise conducted on a treadmill. Moderate intensity exercise defined as (220-age)\*0.6.

Trial Locations (1)

Unknown

Western University, London

All Listed Sponsors
lead

Western University, Canada

OTHER

NCT03400423 - The Acute Effects of Caffeine on Exercise and Cognition | Biotech Hunter | Biotech Hunter